mAbVista Overview
- Year Founded
-
2011
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
mAbVista General Information
Description
Operator of a biotechnology firm designed to specialize in the production of high quality monoclonal antibodies. The company's products provides highly specific, sensitive and versatile microscopy-qualified monoclonal antibodies for the acceleration and advancement of proteomics, enabling researchers to perform quantitative single cell analysis and high content drug screening.
Contact Information
Website
www.mabvista.comCorporate Office
- Two Greenway Plaza
- Suite 910
- Houston, TX 77046
- United States
Corporate Office
- Two Greenway Plaza
- Suite 910
- Houston, TX 77046
- United States
mAbVista Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Sep-2019 | Completed | Out of Business | |||
| 1. Early Stage VC | Completed | Generating Revenue |
mAbVista Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
mAbVista FAQs
-
When was mAbVista founded?
mAbVista was founded in 2011.
-
Who is the founder of mAbVista?
Dean Edwards Ph.D and Michael Mancini Ph.D are the founders of mAbVista.
-
Where is mAbVista headquartered?
mAbVista is headquartered in Houston, TX.
-
What industry is mAbVista in?
mAbVista’s primary industry is Biotechnology.
-
Is mAbVista a private or public company?
mAbVista is a Private company.
-
What is mAbVista’s current revenue?
The current revenue for mAbVista is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
